| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6828855 | Schizophrenia Research | 2008 | 10 Pages |
Abstract
In conclusion, subcutaneous olanzapine infusion in female rats leads to weight gain and metabolic changes of which several are reversed following liraglutide treatment. It may therefore be relevant to study these effects of liraglutide in patients treated with atypically antipsychotics.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Kirsten Lykkegaard, Philip J. Larsen, Niels Vrang, Camilla Bock, Troels Bock, Lotte Bjerre Knudsen,